Brivaracetam has higher SV2A affinity and goes faster to brain. It has a good tolerability and retention rate 60-70% after 6 months. Improvement in psychobehavioral adverse events following the switch from levetiracetam to brivaracetam in about 60% cases. Provide effective seizure control and seizure freedom.